Metabolic correlates of lesion-specific plasticity: an in vivo imaging study

Halleh M Mir1, Keith J Tatsukawa, S Thomas Carmichael

  • 1Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA.

Brain Research
|February 28, 2004
PubMed

Insights

High-resolution positron emission tomography revealed differing brain glucose metabolism recovery after cortical aspiration (ASP) versus thermocoagulation (TCL) lesions. ASP lesions showed greater long-term metabolic deficits compared to TCL, suggesting reduced compensatory capacity.

Area of Science:

  • Neuroscience
  • Medical Imaging

Background:

  • High-resolution positron emission tomography (microPET) enables longitudinal brain function monitoring.
  • Previous work showed altered glucose metabolism in ASP lesions.

Purpose of the Study:

  • Compare glucose metabolism post-cortical aspiration (ASP) and thermocoagulation (TCL) lesions using microPET.
  • Correlate metabolic changes with known anatomical and functional differences between lesion models.

Main Methods:

  • Utilized [(18)F] fluorodeoxyglucose (FDG) microPET to assess brain glucose metabolism.
  • Scanned animals at 3 days, 10 days, and 1 month post-injury.
  • Compared metabolic recovery between ASP and TCL lesion groups.

Main Results:

  • Both ASP and TCL induced ipsilateral neostriatal and thalamic hypometabolism, with partial recovery over time.
  • No significant difference in lesion size at 1 month.
  • ASP lesions resulted in greater subcortical and cortical metabolic deficits at 1 month compared to TCL.

Conclusions:

  • Cortical aspiration and thermocoagulation lesions exhibit distinct metabolic recovery patterns.
  • ASP lesions are associated with a diminished capacity for contralateral cortical compensation compared to TCL.

Related Concept Videos